Role Reversal I: What Are the Weaknesses of Point of Care and Genotyping for Clinical Use? Are We SelfDelusional? - Paul Gurbel, MD, FSCAI

Target Audience

• Interventional Cardiologists
• Interventional Fellows

Session Name: Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate

Track: Coronary

Learning Objectives

• Update in advances in ACS & AMI Management

Other Components in this Moment